FM
Frazier Management Portfolio holdings
AUM
$1.12M
This Quarter Return
+11.06%
1 Year Return
+150.24%
3 Year Return
+430.4%
5 Year Return
+1,926.83%
10 Year Return
–
AUM
$603M
AUM Growth
+$603M
(-2.3%)
Cap. Flow
-$39.9M
Cap. Flow
% of AUM
-6.63%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
11
New
2
Increased
–
Reduced
–
Closed
1
Top Buys
| 1 |
ARMO
ARMO BioSciences, Inc. Common Stock
ARMO
|
$11.2M |
| 2 |
Synlogic
SYBX
|
$6.88M |
Top Sells
| 1 |
RXDX
Ignyta, Inc.
RXDX
|
$58M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
AnaptysBio
ANAB
$569M
| $384M | 63.7% | 3,688,448 | – | – |
|
2
Collegium Pharmaceutical
COLL
$1.22B
| $48.2M | 8% | 1,887,332 | – | – |
|
3
Amicus Therapeutics
FOLD
$2.34B
| $39.1M | 6.49% | 2,600,014 | – | – |
|
4
Iovance Biotherapeutics
IOVA
$807M
| $37M | 6.14% | 2,188,331 | – | – |
|
|
ALNA
5
DELISTED
Allena Pharmaceuticals, Inc. Common Stock
ALNA
| $36.7M | 6.09% | 3,330,373 | – | – |
|
|
ALPN
6
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
| $17.6M | 2.92% | 2,199,011 | – | – |
|
|
SRRA
7
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
| $16.8M | 2.79% | 8,112,121 | – | – |
|
|
ARMO
8
DELISTED
ARMO BioSciences, Inc. Common Stock
ARMO
| $11.2M | 1.86% | +300,000 | New | +$11.2M |
|
|
9
Synlogic
SYBX
$17M
| $6.88M | 1.14% | +733,675 | New | +$6.88M |
|
10
Cidara Therapeutics
CDTX
$1.66B
| $5.25M | 0.87% | 1,312,258 | – | – |
|
|
RXDX
11
DELISTED
Ignyta, Inc.
RXDX
| – | – | -2,173,693 | Closed | -$58M |
|